Study of Adavosertib(AZD1775) in Japanese Patients With Advanced Solid Tumours
Status:
Active, not recruiting
Trial end date:
2021-07-15
Target enrollment:
Participant gender:
Summary
This is a phase I, open-label study to assess the safety, tolerability, pharmacokinetics(PK)
and anti-tumour activity of adavosertib in Japanese patients with advanced solid tumours.
This study consists of 2 cohorts, Cohort1 and Cohort2. At least 3, or up to 6, evaluable
Japanese patients with advanced solid tumours will be enrolled in each cohort to confirm the
tolerability.